Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study
To evaluate postoperative outcomes among patients undergoing colon surgery who receive perioperative prophylaxis with ertapenem compared to other antibiotic regimens. Multicenter retrospective cohort study among adults undergoing colon surgery in seven hospitals across three health systems from 1/1/...
Gespeichert in:
| Veröffentlicht in: | Infection control and hospital epidemiology 2024-10, Vol.45 (10), p.1162-1167 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1167 |
|---|---|
| container_issue | 10 |
| container_start_page | 1162 |
| container_title | Infection control and hospital epidemiology |
| container_volume | 45 |
| creator | Hostler, Christopher J. Krishnan, Jay Parish, Alice Baroco, Allison Cooper, Penny Donceras, Onofre Lautenbach, Ebbing Tolomeo, Pam Sansossio, Tracy Santos, Carlos A.Q. Schwartz, David Zhang, Helen Welbel, Sharon Lokhnygina, Yuliya Anderson, Deverick J. |
| description | To evaluate postoperative outcomes among patients undergoing colon surgery who receive perioperative prophylaxis with ertapenem compared to other antibiotic regimens.
Multicenter retrospective cohort study among adults undergoing colon surgery in seven hospitals across three health systems from 1/1/2010 to 9/1/2015.
Generalized linear mixed logistic regression models were applied to assess differential odds of select outcomes among patients who received perioperative prophylaxis with ertapenem compared to other regimens. Postoperative outcomes of interest included surgical site infection (SSI),
infection (CDI) and clinical culture positivity for carbapenem-resistant
(CRE). Inverse probability weights were applied to account for differing covariate distributions across ertapenem and non-ertapenem groups.
A total of 2,109 patients were included for analysis. The odds of postoperative SSI was 1.56 times higher among individuals who received ertapenem than among those receiving other perioperative antimicrobial prophylaxis regimens in our cohort (46 [3.5%] vs 20 [2.5%]; IPW-weighted OR 1.56, [95% CI, 1.08-2.26],
= .02). No statistically significant differences in odds of postoperative CDI (24 [1.8%] vs 16 [2.0%]; IPW-weighted OR 1.07 [95% CI, .68-1.68],
= .78) were observed between patients who received ertapenem prophylaxis compared to other regimens. Clinical CRE culture positivity was rare in both groups (.2%-.5%) and did not differ statistically.
Ertapenem use for perioperative prophylaxis was associated with increased odds of SSI among patients undergoing colon surgery in our study population, though no differences in CDI or clinical CRE culture positivity were identified. Further study and replication of these findings are needed. |
| doi_str_mv | 10.1017/ice.2024.99 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11611502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_ice_2024_99</cupid><sourcerecordid>3134805910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-1a9458f57ba2cb17530cf4524094ab95cddb135e82a848cf4d1e8ee40b632b33</originalsourceid><addsrcrecordid>eNptkU2LFDEQhoMo7rh68i4BL4L0mM-exMsii1-woIc9eAtJunomS3enTdKL8wv822accf3AUx3q4am3qhB6SsmaErp5FTysGWFirfU9tKJS6qZVXNxHK6K0bhTjX87Qo5xvCCEbrelDdMY1b7nU7Qp9_xxziTMkW8It4LgUH0fI2PYFEk7gIcwFxx5DKnaGCUZspxLG4FN0wQ54TnHe7Qf7LWTcx4R9HOKE85K2kPavscXjMpQacTr6Sop5Bv9zmI-7mArOZen2j9GD3g4ZnpzqObp-9_b68kNz9en9x8s3V41nWpeGWi2k6uXGWeYd3UhOfC8kE0QL67T0Xecol6CYVULVVkdBAQjiWs4c5-fo4qidFzdCd4iV7GDmFEab9ibaYP7uTGFntvHWUNpSKgmrhhcnQ4pfF8jFjCF7GAY7QVyy4ZQyJZVgsqLP_0Fv4pKmul6luFBEakoq9fJI1YvmnKC_S0OJOTzY1OuZw4ON1pV-9ucCd-yvj1agOens6FLotvB76v-EPwB81rUw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134805910</pqid></control><display><type>article</type><title>Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study</title><source>Cambridge University Press Journals Complete</source><creator>Hostler, Christopher J. ; Krishnan, Jay ; Parish, Alice ; Baroco, Allison ; Cooper, Penny ; Donceras, Onofre ; Lautenbach, Ebbing ; Tolomeo, Pam ; Sansossio, Tracy ; Santos, Carlos A.Q. ; Schwartz, David ; Zhang, Helen ; Welbel, Sharon ; Lokhnygina, Yuliya ; Anderson, Deverick J.</creator><creatorcontrib>Hostler, Christopher J. ; Krishnan, Jay ; Parish, Alice ; Baroco, Allison ; Cooper, Penny ; Donceras, Onofre ; Lautenbach, Ebbing ; Tolomeo, Pam ; Sansossio, Tracy ; Santos, Carlos A.Q. ; Schwartz, David ; Zhang, Helen ; Welbel, Sharon ; Lokhnygina, Yuliya ; Anderson, Deverick J. ; CDC Prevention Epicenters Program ; for the CDC Prevention Epicenters Program</creatorcontrib><description>To evaluate postoperative outcomes among patients undergoing colon surgery who receive perioperative prophylaxis with ertapenem compared to other antibiotic regimens.
Multicenter retrospective cohort study among adults undergoing colon surgery in seven hospitals across three health systems from 1/1/2010 to 9/1/2015.
Generalized linear mixed logistic regression models were applied to assess differential odds of select outcomes among patients who received perioperative prophylaxis with ertapenem compared to other regimens. Postoperative outcomes of interest included surgical site infection (SSI),
infection (CDI) and clinical culture positivity for carbapenem-resistant
(CRE). Inverse probability weights were applied to account for differing covariate distributions across ertapenem and non-ertapenem groups.
A total of 2,109 patients were included for analysis. The odds of postoperative SSI was 1.56 times higher among individuals who received ertapenem than among those receiving other perioperative antimicrobial prophylaxis regimens in our cohort (46 [3.5%] vs 20 [2.5%]; IPW-weighted OR 1.56, [95% CI, 1.08-2.26],
= .02). No statistically significant differences in odds of postoperative CDI (24 [1.8%] vs 16 [2.0%]; IPW-weighted OR 1.07 [95% CI, .68-1.68],
= .78) were observed between patients who received ertapenem prophylaxis compared to other regimens. Clinical CRE culture positivity was rare in both groups (.2%-.5%) and did not differ statistically.
Ertapenem use for perioperative prophylaxis was associated with increased odds of SSI among patients undergoing colon surgery in our study population, though no differences in CDI or clinical CRE culture positivity were identified. Further study and replication of these findings are needed.</description><identifier>ISSN: 0899-823X</identifier><identifier>ISSN: 1559-6834</identifier><identifier>EISSN: 1559-6834</identifier><identifier>DOI: 10.1017/ice.2024.99</identifier><identifier>PMID: 39363596</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Antibiotics ; Antimicrobial agents ; Cohort analysis ; Colon ; Colorectal surgery ; Demographics ; Disease prevention ; Ethnicity ; Hispanic Americans ; Hospitals ; Infections ; Laparoscopy ; Medical diagnosis ; Original ; Original Article ; Patients ; Postoperative period ; Prophylaxis ; Surgical outcomes ; Toxins</subject><ispartof>Infection control and hospital epidemiology, 2024-10, Vol.45 (10), p.1162-1167</ispartof><rights>The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America</rights><rights>The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c299t-1a9458f57ba2cb17530cf4524094ab95cddb135e82a848cf4d1e8ee40b632b33</cites><orcidid>0000-0002-5775-0457 ; 0000-0002-6224-0371 ; 0000-0001-6882-5496 ; 0000-0002-7268-4822 ; 0000-0001-5594-8884 ; 0009-0008-6791-4671 ; 0000-0002-2577-5238</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0899823X24000990/type/journal_article$$EHTML$$P50$$Gcambridge$$Hfree_for_read</linktohtml><link.rule.ids>164,230,314,780,784,885,27924,27925,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39363596$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hostler, Christopher J.</creatorcontrib><creatorcontrib>Krishnan, Jay</creatorcontrib><creatorcontrib>Parish, Alice</creatorcontrib><creatorcontrib>Baroco, Allison</creatorcontrib><creatorcontrib>Cooper, Penny</creatorcontrib><creatorcontrib>Donceras, Onofre</creatorcontrib><creatorcontrib>Lautenbach, Ebbing</creatorcontrib><creatorcontrib>Tolomeo, Pam</creatorcontrib><creatorcontrib>Sansossio, Tracy</creatorcontrib><creatorcontrib>Santos, Carlos A.Q.</creatorcontrib><creatorcontrib>Schwartz, David</creatorcontrib><creatorcontrib>Zhang, Helen</creatorcontrib><creatorcontrib>Welbel, Sharon</creatorcontrib><creatorcontrib>Lokhnygina, Yuliya</creatorcontrib><creatorcontrib>Anderson, Deverick J.</creatorcontrib><creatorcontrib>CDC Prevention Epicenters Program</creatorcontrib><creatorcontrib>for the CDC Prevention Epicenters Program</creatorcontrib><title>Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study</title><title>Infection control and hospital epidemiology</title><addtitle>Infect. Control Hosp. Epidemiol</addtitle><description>To evaluate postoperative outcomes among patients undergoing colon surgery who receive perioperative prophylaxis with ertapenem compared to other antibiotic regimens.
Multicenter retrospective cohort study among adults undergoing colon surgery in seven hospitals across three health systems from 1/1/2010 to 9/1/2015.
Generalized linear mixed logistic regression models were applied to assess differential odds of select outcomes among patients who received perioperative prophylaxis with ertapenem compared to other regimens. Postoperative outcomes of interest included surgical site infection (SSI),
infection (CDI) and clinical culture positivity for carbapenem-resistant
(CRE). Inverse probability weights were applied to account for differing covariate distributions across ertapenem and non-ertapenem groups.
A total of 2,109 patients were included for analysis. The odds of postoperative SSI was 1.56 times higher among individuals who received ertapenem than among those receiving other perioperative antimicrobial prophylaxis regimens in our cohort (46 [3.5%] vs 20 [2.5%]; IPW-weighted OR 1.56, [95% CI, 1.08-2.26],
= .02). No statistically significant differences in odds of postoperative CDI (24 [1.8%] vs 16 [2.0%]; IPW-weighted OR 1.07 [95% CI, .68-1.68],
= .78) were observed between patients who received ertapenem prophylaxis compared to other regimens. Clinical CRE culture positivity was rare in both groups (.2%-.5%) and did not differ statistically.
Ertapenem use for perioperative prophylaxis was associated with increased odds of SSI among patients undergoing colon surgery in our study population, though no differences in CDI or clinical CRE culture positivity were identified. Further study and replication of these findings are needed.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Cohort analysis</subject><subject>Colon</subject><subject>Colorectal surgery</subject><subject>Demographics</subject><subject>Disease prevention</subject><subject>Ethnicity</subject><subject>Hispanic Americans</subject><subject>Hospitals</subject><subject>Infections</subject><subject>Laparoscopy</subject><subject>Medical diagnosis</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Postoperative period</subject><subject>Prophylaxis</subject><subject>Surgical outcomes</subject><subject>Toxins</subject><issn>0899-823X</issn><issn>1559-6834</issn><issn>1559-6834</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>IKXGN</sourceid><recordid>eNptkU2LFDEQhoMo7rh68i4BL4L0mM-exMsii1-woIc9eAtJunomS3enTdKL8wv822accf3AUx3q4am3qhB6SsmaErp5FTysGWFirfU9tKJS6qZVXNxHK6K0bhTjX87Qo5xvCCEbrelDdMY1b7nU7Qp9_xxziTMkW8It4LgUH0fI2PYFEk7gIcwFxx5DKnaGCUZspxLG4FN0wQ54TnHe7Qf7LWTcx4R9HOKE85K2kPavscXjMpQacTr6Sop5Bv9zmI-7mArOZen2j9GD3g4ZnpzqObp-9_b68kNz9en9x8s3V41nWpeGWi2k6uXGWeYd3UhOfC8kE0QL67T0Xecol6CYVULVVkdBAQjiWs4c5-fo4qidFzdCd4iV7GDmFEab9ibaYP7uTGFntvHWUNpSKgmrhhcnQ4pfF8jFjCF7GAY7QVyy4ZQyJZVgsqLP_0Fv4pKmul6luFBEakoq9fJI1YvmnKC_S0OJOTzY1OuZw4ON1pV-9ucCd-yvj1agOens6FLotvB76v-EPwB81rUw</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Hostler, Christopher J.</creator><creator>Krishnan, Jay</creator><creator>Parish, Alice</creator><creator>Baroco, Allison</creator><creator>Cooper, Penny</creator><creator>Donceras, Onofre</creator><creator>Lautenbach, Ebbing</creator><creator>Tolomeo, Pam</creator><creator>Sansossio, Tracy</creator><creator>Santos, Carlos A.Q.</creator><creator>Schwartz, David</creator><creator>Zhang, Helen</creator><creator>Welbel, Sharon</creator><creator>Lokhnygina, Yuliya</creator><creator>Anderson, Deverick J.</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5775-0457</orcidid><orcidid>https://orcid.org/0000-0002-6224-0371</orcidid><orcidid>https://orcid.org/0000-0001-6882-5496</orcidid><orcidid>https://orcid.org/0000-0002-7268-4822</orcidid><orcidid>https://orcid.org/0000-0001-5594-8884</orcidid><orcidid>https://orcid.org/0009-0008-6791-4671</orcidid><orcidid>https://orcid.org/0000-0002-2577-5238</orcidid></search><sort><creationdate>20241001</creationdate><title>Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study</title><author>Hostler, Christopher J. ; Krishnan, Jay ; Parish, Alice ; Baroco, Allison ; Cooper, Penny ; Donceras, Onofre ; Lautenbach, Ebbing ; Tolomeo, Pam ; Sansossio, Tracy ; Santos, Carlos A.Q. ; Schwartz, David ; Zhang, Helen ; Welbel, Sharon ; Lokhnygina, Yuliya ; Anderson, Deverick J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-1a9458f57ba2cb17530cf4524094ab95cddb135e82a848cf4d1e8ee40b632b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Cohort analysis</topic><topic>Colon</topic><topic>Colorectal surgery</topic><topic>Demographics</topic><topic>Disease prevention</topic><topic>Ethnicity</topic><topic>Hispanic Americans</topic><topic>Hospitals</topic><topic>Infections</topic><topic>Laparoscopy</topic><topic>Medical diagnosis</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Postoperative period</topic><topic>Prophylaxis</topic><topic>Surgical outcomes</topic><topic>Toxins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hostler, Christopher J.</creatorcontrib><creatorcontrib>Krishnan, Jay</creatorcontrib><creatorcontrib>Parish, Alice</creatorcontrib><creatorcontrib>Baroco, Allison</creatorcontrib><creatorcontrib>Cooper, Penny</creatorcontrib><creatorcontrib>Donceras, Onofre</creatorcontrib><creatorcontrib>Lautenbach, Ebbing</creatorcontrib><creatorcontrib>Tolomeo, Pam</creatorcontrib><creatorcontrib>Sansossio, Tracy</creatorcontrib><creatorcontrib>Santos, Carlos A.Q.</creatorcontrib><creatorcontrib>Schwartz, David</creatorcontrib><creatorcontrib>Zhang, Helen</creatorcontrib><creatorcontrib>Welbel, Sharon</creatorcontrib><creatorcontrib>Lokhnygina, Yuliya</creatorcontrib><creatorcontrib>Anderson, Deverick J.</creatorcontrib><creatorcontrib>CDC Prevention Epicenters Program</creatorcontrib><creatorcontrib>for the CDC Prevention Epicenters Program</creatorcontrib><collection>Cambridge University Press Wholly Gold Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infection control and hospital epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hostler, Christopher J.</au><au>Krishnan, Jay</au><au>Parish, Alice</au><au>Baroco, Allison</au><au>Cooper, Penny</au><au>Donceras, Onofre</au><au>Lautenbach, Ebbing</au><au>Tolomeo, Pam</au><au>Sansossio, Tracy</au><au>Santos, Carlos A.Q.</au><au>Schwartz, David</au><au>Zhang, Helen</au><au>Welbel, Sharon</au><au>Lokhnygina, Yuliya</au><au>Anderson, Deverick J.</au><aucorp>CDC Prevention Epicenters Program</aucorp><aucorp>for the CDC Prevention Epicenters Program</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study</atitle><jtitle>Infection control and hospital epidemiology</jtitle><addtitle>Infect. Control Hosp. Epidemiol</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>45</volume><issue>10</issue><spage>1162</spage><epage>1167</epage><pages>1162-1167</pages><issn>0899-823X</issn><issn>1559-6834</issn><eissn>1559-6834</eissn><abstract>To evaluate postoperative outcomes among patients undergoing colon surgery who receive perioperative prophylaxis with ertapenem compared to other antibiotic regimens.
Multicenter retrospective cohort study among adults undergoing colon surgery in seven hospitals across three health systems from 1/1/2010 to 9/1/2015.
Generalized linear mixed logistic regression models were applied to assess differential odds of select outcomes among patients who received perioperative prophylaxis with ertapenem compared to other regimens. Postoperative outcomes of interest included surgical site infection (SSI),
infection (CDI) and clinical culture positivity for carbapenem-resistant
(CRE). Inverse probability weights were applied to account for differing covariate distributions across ertapenem and non-ertapenem groups.
A total of 2,109 patients were included for analysis. The odds of postoperative SSI was 1.56 times higher among individuals who received ertapenem than among those receiving other perioperative antimicrobial prophylaxis regimens in our cohort (46 [3.5%] vs 20 [2.5%]; IPW-weighted OR 1.56, [95% CI, 1.08-2.26],
= .02). No statistically significant differences in odds of postoperative CDI (24 [1.8%] vs 16 [2.0%]; IPW-weighted OR 1.07 [95% CI, .68-1.68],
= .78) were observed between patients who received ertapenem prophylaxis compared to other regimens. Clinical CRE culture positivity was rare in both groups (.2%-.5%) and did not differ statistically.
Ertapenem use for perioperative prophylaxis was associated with increased odds of SSI among patients undergoing colon surgery in our study population, though no differences in CDI or clinical CRE culture positivity were identified. Further study and replication of these findings are needed.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><pmid>39363596</pmid><doi>10.1017/ice.2024.99</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5775-0457</orcidid><orcidid>https://orcid.org/0000-0002-6224-0371</orcidid><orcidid>https://orcid.org/0000-0001-6882-5496</orcidid><orcidid>https://orcid.org/0000-0002-7268-4822</orcidid><orcidid>https://orcid.org/0000-0001-5594-8884</orcidid><orcidid>https://orcid.org/0009-0008-6791-4671</orcidid><orcidid>https://orcid.org/0000-0002-2577-5238</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0899-823X |
| ispartof | Infection control and hospital epidemiology, 2024-10, Vol.45 (10), p.1162-1167 |
| issn | 0899-823X 1559-6834 1559-6834 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11611502 |
| source | Cambridge University Press Journals Complete |
| subjects | Antibiotics Antimicrobial agents Cohort analysis Colon Colorectal surgery Demographics Disease prevention Ethnicity Hispanic Americans Hospitals Infections Laparoscopy Medical diagnosis Original Original Article Patients Postoperative period Prophylaxis Surgical outcomes Toxins |
| title | Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A06%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postoperative%20outcomes%20after%20receipt%20of%20ertapenem%20antimicrobial%20prophylaxis%20for%20colon%20surgery:%20a%20multicenter%20retrospective%20cohort%20study&rft.jtitle=Infection%20control%20and%20hospital%20epidemiology&rft.au=Hostler,%20Christopher%20J.&rft.aucorp=CDC%20Prevention%20Epicenters%20Program&rft.date=2024-10-01&rft.volume=45&rft.issue=10&rft.spage=1162&rft.epage=1167&rft.pages=1162-1167&rft.issn=0899-823X&rft.eissn=1559-6834&rft_id=info:doi/10.1017/ice.2024.99&rft_dat=%3Cproquest_pubme%3E3134805910%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134805910&rft_id=info:pmid/39363596&rft_cupid=10_1017_ice_2024_99&rfr_iscdi=true |